Inflammatory bowel disease (IBD)-related colorectal cancer (CRC) is responsible for
approximately 2% of the annual mortality from CRC overall, but 10–15% of the annual …

Simple Summary Although the incidence of inflammatory bowel disease (IBD)-related
cancer has been decreasing, its prognosis remains worse than that of non-IBD-related …

New chemopreventive alternatives are needed due to the rising worldwide incidence of
colorectal cancer. The objective was to evaluate the chemopreventive activity of Moringa …

Objective: The aim of our study was to conduct a systematic review and meta-analysis
comparing the survival outcomes of IBD-associated and non-IBD-associated CRC …

Cumulative evidence indicates that a significant proportion of cancer evolution may occur
before the development of histological abnormalities. While recent improvements in DNA …

Consistent experimental data suggest the importance of inflammation-associated oxidative
stress in colorectal cancer (CRC) pathogenesis. Inflammatory bowel disease with chronic …

Redox biology has become a major issue in numerous areas of physiology. Reactive
oxygen species (ROS) have a broad range of roles from signal transduction to growth …

Background Due to experimental batch effects, the application of a quantitative
transcriptional signature for disease diagnoses commonly requires inter-sample data …

Numerous studies have demonstrated that diets containing an increased ratio of ω-6: ω-3
polyunsaturated fatty acids (PUFAs) are a risk factor for colon cancer and might affect …

Nuclear receptors (NRs) are ligand‐dependent transcription factors that regulate the
transcription of target genes. Previous epidemiological and genetic studies have …